Savage, K. T., Santillan, M. R., Flood, K. S., Charrow, A., Porter, M. L., & Kimball, A. B. (2020). Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Rep.
Chicago Style CitationSavage, Kevin T., Monica Rosales Santillan, Kelsey S. Flood, Alexandra Charrow, Martina L. Porter, i Alexa B. Kimball. "Tofacitinib Shows Benefit in Conjunction With Other Therapies in Recalcitrant Hidradenitis Suppurativa Patients." JAAD Case Rep 2020.
Cita MLASavage, Kevin T., et al. "Tofacitinib Shows Benefit in Conjunction With Other Therapies in Recalcitrant Hidradenitis Suppurativa Patients." JAAD Case Rep 2020.
Atenció: Aquestes cites poden no estar 100% correctes.